Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report

BACKGROUND: We present the first full case report of the treatment of mast cell activation syndrome with continuous diphenhydramine infusion, which resulted in the improvement of anaphylactic reactions and a decrease in hospital readmission. Furthermore, the patient received imatinib in the absence...

Descripción completa

Detalles Bibliográficos
Autores principales: Malik, Faizan, Ali, Naveed, Jafri, Syed Imran Mustafa, Ghani, Ali, Hamid, Mohsin, Boigon, Margot, Fidler, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402659/
https://www.ncbi.nlm.nih.gov/pubmed/28438191
http://dx.doi.org/10.1186/s13256-017-1278-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402659/
https://www.ncbi.nlm.nih.gov/pubmed/28438191
http://dx.doi.org/10.1186/s13256-017-1278-3

Ejemplares similares